Neglected Tropical Disease Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030

Neglected Tropical Disease Diagnosis Trends and Forecast

The future of the global neglected tropical disease diagnosis market looks promising with opportunities in the hospital and clinic, home healthcare, and clinical laboratory markets. The global neglected tropical disease diagnosis market is expected to grow with a CAGR of 4.9% from 2024 to 2030. The major drivers for this market are escalating number of overlooked tropical diseases, rising demand for rapid diagnostic tests, and mounting recognition of NTDs.

A more than 150-page report is developed to help in your business decisions.

Neglected Tropical Disease Diagnosis by Segment

The study includes a forecast for the global neglected tropical disease diagnosis by disease type, method, service type, end use, and region.

Neglected Tropical Disease Diagnosis Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

• Dengue
• Chikungunya
• Rabies
• Lymphatic Filariasis
• Buruli Ulcer
• Foodborne Trematodiases
• Echinococcosis
• Leprosy
• Others

Neglected Tropical Disease Diagnosis Market by Method [Shipment Analysis by Value from 2018 to 2030]:

• Conventional Method
• Molecular Method

Neglected Tropical Disease Diagnosis Market by Service Type [Shipment Analysis by Value from 2018 to 2030]:

• Centralized Service
• Point-of-Care Testing

Neglected Tropical Disease Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospital and Clinic
• Home Healthcare
• Clinical Laboratories
• Others

Neglected Tropical Disease Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Neglected Tropical Disease Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neglected tropical disease diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neglected tropical disease diagnosis companies profiled in this report include-

• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• InBios International
• Omega Diagnostics
• Oscar Medicare
• EUROIMMUN
• Novartis
• Grifols
• ZeptoMetrix
• DiaSys Diagnostic Systems

Neglected Tropical Disease Diagnosis Market Insights

Lucintel forecasts that dengue will remain the largest segment over the forecast period due to increasing adoption of point-of-care testing for dengue virus detection in developed nations.

Within this market, clinical laboratory will remain the largest segment due to increased number of laboratories across world and rising availability of advanced equipment in clinical laboratories.

North America will remain the largest segment over the forecast period due to existence of skilled healthcare professionals and growing adoption of point-of-care testing services at home healthcare in the region.

Features of the Global Neglected Tropical Disease Diagnosis Market

Market Size Estimates: Neglected tropical disease diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neglected tropical disease diagnosis market size by various segments, such as by disease type, method, service type, end use, and region in terms of value ($B).

Regional Analysis: Neglected tropical disease diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different disease types, methods, service types, end uses, and regions for the neglected tropical disease diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neglected tropical disease diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for neglected tropical disease diagnosis market?

Answer: The global neglected tropical disease diagnosis market is expected to grow with a CAGR of 4.9% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the neglected tropical disease diagnosis market?

Answer: The major drivers for this market are escalating number of overlooked tropical diseases, rising demand for rapid diagnostic tests and mounting recognition of ntds.

Q3. What are the major segments for neglected tropical disease diagnosis market?

Answer: The future of the neglected tropical disease diagnosis market looks promising with opportunities in the hospital and clinic, home healthcare, and clinical laboratory markets.

Q4. Who are the key neglected tropical disease diagnosis market companies?

Answer: Some of the key neglected tropical disease diagnosis companies are as follows.

• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• InBios International
• Omega Diagnostics
• Oscar Medicare
• EUROIMMUN
• Novartis
• Grifols
• ZeptoMetrix
• DiaSys Diagnostic Systems

Q5. Which neglected tropical disease diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that dengue will remain the largest segment over the forecast period due to increasing adoption of point-of-care testing for dengue virus detection in developed nations.

Q6. In neglected tropical disease diagnosis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to existence of skilled healthcare professionals and growing adoption of point-of-care testing services at home healthcare in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the neglected tropical disease diagnosis market by disease type (dengue, chikungunya, rabies, lymphatic filariasis, buruli ulcer, foodborne trematodiases, echinococcosis, leprosy, and others), method (conventional method and molecular method), service type (centralized service and point-of-care testing), end use (hospital and clinic, home healthcare, clinical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?